Evidence map›Paper›PMID 29931284›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2019

Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness-South Africa, 2009-2014.

Brian Rha, Rebecca M Dahl, Jocelyn Moyes, Alison M Binder, Stefano Tempia, Sibongile Walaza, Daoling Bi, Michelle J Groome, Ebrahim Variava, Fathima Naby and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. The added value of serologic testing: A comparison of influenza incidence among pregnant persons based on molecular-based surveillance versus serologic testing.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 5 countries.

Brian RhaDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia.
Rebecca M DahlDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia.
Jocelyn MoyesCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Alison M BinderDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia.
Stefano TempiaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Sibongile WalazaCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Daoling BiDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia.
Michelle J GroomeMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, Johannesburg, South Africa.
Ebrahim VariavaDepartment of Medicine, Faculty of Health Sciences, Johannesburg, South Africa.
Fathima NabyDepartment of Paediatrics, Pietermaritzburg Metropolitan Hospitals, University of KwaZulu-Natal, South Africa.
Kathleen KahnMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Florette TreurnichtCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Adam L CohenInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Susan I GerberDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia.
Shabir A MadhiCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Cheryl CohenCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.
National Center for Immunization and Respiratory Diseases · USRespiratory and Meningeal Pathogens Research Unit · ZACenters for Disease Control and Prevention · USNational Institute for Communicable DiseasesAgincourt Health and Socio-Demographic Surveillance System · ZAEdendale Hospital · ZAKalafong Hospital · ZAOak Ridge Institute for Science and Education

Funding

Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09U01IP001048 · IP · NATIONAL HEALTH LABORATORY SERVICE · PI COHEN, CHERYL · 2016 to 2020
$19.9M
NCIRD CDC HHS U01 IP001048NCIRD CDC HHS U51 IP000155
6 · The paper itself

Abstract

backgroundRespiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection (ALRTI) in young children, but data on surveillance case definition performance in estimating burdens have been limited.

methodsWe enrolled children aged <5 years hospitalized for ALRTI (or neonatal sepsis in young infants) through active prospective surveillance at 5 sentinel hospitals in South Africa and collected nasopharyngeal aspirates from them for RSV molecular diagnostic testing between 2009 and 2014. Clinical data were used to characterize RSV disease and retrospectively evaluate the performance of respiratory illness case definitions (including the World Health Organization definition for severe acute respiratory infection [SARI]) in identifying hospitalized children with laboratory-confirmed RSV according to age group (<3, 3-5, 6-11, 12-23, and 24-59 months).

resultsOf 9969 hospitalized children, 2723 (27%) tested positive for RSV. Signs and symptoms in RSV-positive children varied according to age; fever was less likely to occur in children aged <3 months (57%; odds ratio [OR], 0.8 [95% CI, 0.7-0.9]) but more likely in those aged ≥12 months (82%; OR, 1.7-1.9) than RSV-negative children. The sensitivity (range, 55%-81%) and specificity (range, 27%-54%) of the SARI case definition to identify hospitalized RSV-positive children varied according to age; the lowest sensitivity was for infants aged <6 months. Using SARI as the case definition would have missed 36% of RSV-positive children aged <5 years and 49% of those aged <3 months; removing the fever requirement from the definition recovered most missed cases.

conclusionIncluding fever in the SARI case definition lowers the sensitivity for RSV case detection among young children hospitalized with an ALRTI and likely underestimates its burden.

Indexed as

Child, HospitalizedChild, PreschoolEpidemiological MonitoringFemaleFeverHumansInfantMaleOdds RatioProspective StudiesRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRetrospective StudiesSensitivity and SpecificitySouth Africacase definitionsrespiratory syncytial virusrespiratory tract infectionsSouth Africasurveillance

Identifiers

PMID29931284
PMCPMC12813577
OpenAlexW2809040246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.